Thunen Shelley B 4
4 · RxSight, Inc. · Filed Apr 15, 2025
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Thunen Shelley B
See remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-04-14−6,405→ 0 totalExercise: $4.34From: 2020-10-27Exp: 2026-10-26→ Common Stock (6,405 underlying) - Exercise/Conversion
Common Stock
2025-04-14$4.34/sh+7,792$33,806→ 38,354 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-14−1,387→ 0 totalExercise: $4.34From: 2021-02-24Exp: 2027-03-13→ Common Stock (1,387 underlying)
Footnotes (2)
- [F1]Includes 119 shares of Common Stock acquired October 31, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.